(Q39301192)

English

CRISPR-Cas9-modified pfmdr1 protects Plasmodium falciparum asexual blood stages and gametocytes against a class of piperazine-containing compounds but potentiates artemisinin-based combination therapy partner drugs

scientific article

Statements

CRISPR-Cas9-modified pfmdr1 protects Plasmodium falciparum asexual blood stages and gametocytes against a class of piperazine-containing compounds but potentiates artemisinin-based combination therapy partner drugs (English)
0 references
0 references
0 references
0 references
0 references
Caroline L Ng
Marcus C S Lee
Mariana J de Almeida
Victoria C Corey
Selina E Bopp
Lucia Bertuccini
Rachel G Kasdin
Amélie Le Bihan
Martine Clozel

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit